Clinical Trials
- Alzheimer's
A Randomized, Double-Blind, Placebo controlled, Parallel-group, Multicenter Study to Assess the Efficacy and Safety of JNJ-63733657, an anti-tau Monoclonal Antibody, in Participants with Early Alzheimer's Disease
- Ages55 years - 80 years
- GenderBoth
- Mental Health & Behavioral Research, Alzheimer's
Ketamine for the Treatment of Depression in Parkinson's Disease
- Ages40 years - 70 years
- GenderBoth
- Mental Health & Behavioral Research
Predictive Coding and Unusual Experiences
- Ages18 years - 55 years
- GenderBoth
- Children's Health, Diseases of the Respiratory Systems
Efficacy and Safety of OPN-375 186 ug Twice a Day (BID) in Adolescents with Bilateral Nasal Polyps
- Ages12 years - 17 years
- GenderBoth
- COVID-19 Inpatient, COVID-19 Outpatient
The RECOVER Long Covid Study at Yale
- Ages25 years and younger
- GenderBoth
- Mental Health & Behavioral Research, COVID-19 Inpatient, COVID-19 Outpatient
Have you had COVID-19?
- COVID-19 Inpatient, COVID-19 Outpatient
Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)
- Ages18 years and older
- GenderBoth
- COVID-19 Outpatient
Magnetic Resonance Imaging Biomarkers: A tool to study central nervous system disease (MBAT)
- COVID-19 Outpatient
Topical Antibacterial Agents for Prevention of COVID-19
- Ages18 years - 60 years
- GenderBoth
- Women's Health, COVID-19 Inpatient, COVID-19 Outpatient
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
- Ages18 years and older
- GenderBoth